Literature DB >> 9706431

Ototoxicity due to hydroxychloroquine: report of two cases.

P B Johansen1, J T Gran.   

Abstract

We report two cases of irreversible sensineuronal hearing loss due to hydroxychloroquine treatment. The first patient was a 44-year-old woman with long-standing systemic lupus erythematosus and the second case was a 44-year-old man with clinical manifestations consistent with subacute cutaneous lupus erythematosus. They both developed irreversible hearing loss after several years of hydroxychloroquine treatment. Sensineuronal deafness has previously been reported in connection with chloroquine treatment, but this is the first report of ototoxicity associated with hydroxychloroquine.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9706431

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  8 in total

Review 1.  Beyond the joints: neurological involvement in rheumatoid arthritis.

Authors:  Cesar Ramos-Remus; Sergio Duran-Barragan; Jose Dionisio Castillo-Ortiz
Journal:  Clin Rheumatol       Date:  2011-09-20       Impact factor: 2.980

2.  Cumulative disease activity predicts incidental hearing impairment in patients with rheumatoid arthritis (RA).

Authors:  Virginia Pascual-Ramos; Irazú Contreras-Yáñez; Paula Rivera-Hoyos; Lorena Enríquez; Jaqueline Ramírez-Anguiano
Journal:  Clin Rheumatol       Date:  2014-01-18       Impact factor: 2.980

Review 3.  Chloroquine ototoxicity.

Authors:  Rodrigo Bortoli; Mittermayer Santiago
Journal:  Clin Rheumatol       Date:  2007-06-27       Impact factor: 2.980

4.  A case report of hearing loss post use of hydroxychloroquine in a HIV-infected patient.

Authors:  Hossein Khalili; Farzaneh Dastan; Seyed Ali Dehghan Manshadi
Journal:  Daru       Date:  2014-01-22       Impact factor: 3.117

Review 5.  Therapeutic use of chloroquine and hydroxychloroquine in COVID-19 and other viral infections: A narrative review.

Authors:  Anwar M Hashem; Badrah S Alghamdi; Abdullah A Algaissi; Fahad S Alshehri; Abdullah Bukhari; Mohamed A Alfaleh; Ziad A Memish
Journal:  Travel Med Infect Dis       Date:  2020-05-06       Impact factor: 6.211

Review 6.  Clinical Implications of Chloroquine and Hydroxychloroquine Ototoxicity for COVID-19 Treatment: A Mini-Review.

Authors:  Pattarawadee Prayuenyong; Anand V Kasbekar; David M Baguley
Journal:  Front Public Health       Date:  2020-05-29

Review 7.  The Ototoxicity of Chloroquine and Hydroxychloroquine: A Systematic Review.

Authors:  Carolina Pereira Fernandes; Luíza Silva Vernier; Eliane Dallegrave; Márcia Salgado Machado
Journal:  Int Arch Otorhinolaryngol       Date:  2022-01-25

8.  Mild and moderate COVID-19 disease does not affect hearing function permanently: a cross-sectional study ınvolving young and middle-aged healthcare givers.

Authors:  Kerem Kökoğlu; Nezaket Tektaş; Fidan Elif Baktir-Okcesiz; Mehmet İlhan Şahin
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-06-29       Impact factor: 2.503

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.